Medicus Pharma Reports GAAP EPS $2.74: Medicus Pharma reported GAAP EPS of $2.74 on Mar 26, 2026 (Seeking Alpha); investors should await the 8-K/10-Q for reconciliations and details on recurring revenue. 👈 Read full analysis #MedicusPharma #GAAPEPS #Investing #FinanceNews #StockMarket
Medicus Pharma Reports GAAP EPS $2.74
Medicus Pharma reported GAAP EPS of $2.74 on Mar 26, 2026 (Seeking Alpha); investors should await the 8-K/10-Q for reconciliations and details on recurring revenue.
dlvr.it
March 26, 2026 at 10:00 AM
Medicus Pharma Reports GAAP EPS $2.74: Medicus Pharma reported GAAP EPS of $2.74 on Mar 26, 2026 (Seeking Alpha); investors should await the 8-K/10-Q for reconciliations and details on recurring revenue. 👈 Read full analysis #MedicusPharma #GAAPEPS #Investing #FinanceNews #StockMarket
#MedicusPharma CEO Dr #RazaBokhari joined Steve Darling from Proactive to announce a significant regulatory milestone for the company’s SkinJect program, revealing that Protocol SKNJCT-005 has been submitted advances SkinJect toward registrational trial for rare Gorlin Syndrome youtu.be/iLAzA45gvdY
Medicus Pharma advances SkinJect toward registrational trial for rare Gorlin Syndrome
YouTube video by Proactive Investors
youtu.be
June 5, 2026 at 4:04 PM
#MedicusPharma CEO Dr #RazaBokhari joined Steve Darling from Proactive to announce a significant regulatory milestone for the company’s SkinJect program, revealing that Protocol SKNJCT-005 has been submitted advances SkinJect toward registrational trial for rare Gorlin Syndrome youtu.be/iLAzA45gvdY